• 专利标题:   Composite nanostructured protein membrane used as e.g. flexible organic electrode for manufacture of energy storage device, is obtained by physical process of ultrasonication for decrosslinking/crosslinking of eggshell protein membranes or fibrillar proteins.
  • 专利号:   BR102021018053-A2
  • 发明人:   DE MELO C P, GOMES MACIEL B, DA SILVA R J, SANCHEZ L C M, RATKOVSKI G P, ALCARAZ ESPINOZA J J, NASCIMENTO DE SOUSA F, RATKOVSKI D R, PEQUENO DE OLIVEIRA H
  • 专利权人:   UNIV FEDERAL PERNAMBUCO, UNIVASF UNIV SAO FRANCISCO FEDERAL VALE
  • 国际专利分类:   B01D071/74, C08J005/02, C08J005/10, C08L089/00, H01G011/24, H01G011/32
  • 专利详细信息:   BR102021018053-A2 21 Mar 2023 C08J-005/02 202337 Pages: 40
  • 申请详细信息:   BR102021018053-A2 BR10018053 11 Sep 2021
  • 优先权号:   BR10018053

▎ 摘  要

NOVELTY - A composite nanostructured protein membrane is obtained by physical process of ultrasonication for decrosslinking/crosslinking of eggshell protein membranes or fibrillar proteins. USE - Composite nanostructured protein membrane is used as flexible organic electrode for manufacture of energy storage device such as flexible or non-solid-state supercapacitor and/or sensing of biomolecules, gases, dyes, pesticides and other environmental contaminants, and as electrode and/or platform for immobilization and detection of nucleic acid chains of pathogenic agent, proteins and antibodies (all claimed). ADVANTAGE - The composite nanostructured protein membrane produces organic electrode through a simple, fast and low cost process. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for the following: preparation of the composite nanostructured protein membrane, which involves adding a commercial aqueous suspension or performing chemical synthesis of in-situ polymerization of the conductive polymer, during or after the process of preparation by ultrasound of the composite protein membrane to obtain desired properties; and use of the composite nanostructured protein membrane as an electrode and/or a platform for immobilization and detection of nucleic acid chains of pathogenic agent based on biorecognition of specific molecular interactions, with the probe to be used for biorecognition which is being a single-stranded strand of nucleic acid with specific sequence corresponding to the pathogen of interest, and immobilization and detection of proteins and antibodies from a biorecognition of specific molecular interactions, with the probe to be used for biorecognition which is being a specific antigen or antibody corresponding to the disease of interest.